A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus.
about
Use of licensed vaccines for active immunization of the immunocompromised hostA novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus.Overwhelming pneumococcal bacteraemia in systemic lupus erythematosus.European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studiesVaccination and systemic lupus erythematosus: the bidirectional dilemmas.Rethinking recommendations for use of pneumococcal vaccines in adults.C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.Pneumococcal sepsis in patients with systemic lupus erythematosus.Vaccination in patients with chronic rheumatic or autoimmune diseases.Are anti-infectious vaccinations safe and effective in patients with autoimmunity?Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus.Vaccination of patients with autoimmune inflammatory rheumatic diseases.Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis.Advances in our understanding of immunization and vaccines for patients with systemic lupus erythematosus.Vaccinations and autoimmune diseases.Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus.
P2860
Q24533456-E9B269F9-D10E-4A26-BC33-B671E152A5F9Q27693187-0AD7228F-FE0C-4E8B-A8A6-5E865405B49AQ33561613-543DA9D0-E011-48C6-85A7-8181680332FDQ34187282-6EEB87DE-C5A1-49C4-83E7-6CF2E0BDC3FCQ34227160-1E0644E0-403C-49BE-8F5D-C6D83EABAE8AQ34326459-98D2A580-255F-4B4D-A5F7-2582A9B6113BQ35215620-B5D9254E-26CE-4259-A37F-1DACCD9D31DBQ36334477-4BD14E8C-0DDA-4306-84D9-8D05265D05F9Q37141193-B05A2215-291D-4C9B-8094-153F27A4E961Q37762551-B681ECA9-7B9A-40A9-9B12-56649B368CAEQ38182646-C804F27C-C168-4BCB-812B-91CC625A9EACQ38285275-A1CB2A8B-F728-41E7-A711-6699B13C7E96Q38829863-C817CC6F-4A6D-477B-A7E8-024D1879626FQ40106216-363F6C1D-4F48-4D73-A561-F2F99DBB2743Q44440836-00F8702F-75BB-4041-A390-0927794441C3Q44865311-4AA7970C-2724-4768-BF1E-872E1D1C265E
P2860
A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
A controlled study of pneumoco ...... systemic lupus erythematosus.
@en
A controlled study of pneumoco ...... systemic lupus erythematosus.
@nl
type
label
A controlled study of pneumoco ...... systemic lupus erythematosus.
@en
A controlled study of pneumoco ...... systemic lupus erythematosus.
@nl
prefLabel
A controlled study of pneumoco ...... systemic lupus erythematosus.
@en
A controlled study of pneumoco ...... systemic lupus erythematosus.
@nl
P2093
P2860
P356
P1476
A controlled study of pneumoco ...... systemic lupus erythematosus.
@en
P2093
P2860
P304
P356
10.1002/ART.1780221201
P577
1979-12-01T00:00:00Z